In equity investing, joining fundamental strength with positive technical patterns is a method many investors apply to spot possible opportunities. The aim is to locate firms with sound basic business measures, such as good growth, earnings, and financial condition, that are also displaying helpful price movement, indicating the market may be acknowledging that worth. This method tries to match the qualitative narrative of a firm with the quantitative signs of market timing. A stock that performs well on fundamental growth measures while also displaying a technical breakout formation can offer a noteworthy case for more study, as it implies both internal soundness and external market agreement.
Globus Medical Inc - A (NYSE:GMED) recently appeared from a scan made to locate such stocks. The scan selects for technical breakout formations in firms that are increasing well while also keeping acceptable earnings and financial condition. We will look at why GMED seems to fit these joined requirements.
Fundamental Growth and Soundness
The basic attraction of GMED rests in its firm fundamental profile, which matches the central ideas of growth investing. Based on its fundamental analysis report, Globus Medical receives a total score of 7 out of 10, with especially high scores in Profitability (8) and Financial Health (8). Its Growth score is a firm 7. This pairing is important for the method, as it shows the firm is not just getting bigger quickly but is doing so from a place of operational and financial soundness.
Important fundamental points contain:
- Good Past Growth: The firm has shown notable past growth, with Revenue rising by 30.08% on average each year and Earnings Per Share (EPS) increasing by 22.84% on average over recent years.
- High Earnings Margins: GMED's Profit Margin of 18.30% and Operating Margin of 18.30% do better than a large part of its group in the Health Care Equipment & Supplies industry.
- Firm Financial Health: The firm shows a very strong balance sheet, marked by a Debt/Equity ratio of 0.00 and a high Altman-Z score of 11.32, showing low bankruptcy chance and high solvency.
These measures are needed for the scanning method because they imply the firm has the operational quality and financial steadiness to possibly maintain its growth path, a main belief of growth investing which centers on firms thought to outperform the market.
Technical Formation and Market Place
While fundamentals give the "why," technical study can give view into the "when." GMED's technical analysis report notes a Setup Score of 7 out of 10, even as its total technical score is lower because of recent price softness. This setup score is the main technical filter in the scan, made to spot stocks where price movement is coming together in a way that may come before a new move.
The technical view for GMED shows a varied but possibly favorable picture:
- Coming Together Stage: The stock has been coming together recently, with less movement. It is now trading between a clear support area (about $84.51 - $86.39) and a close resistance area (starting near $87.44).
- Long-Term Path Holding: Even with a poor short-term path, the long-term path for GMED stays positive. The stock is still trading in the higher part of its 52-week range, having done much better than the market over the past six months.
- Possible Breakout Situation: The report indicates that a move above the nearby resistance area could offer a technical entry point, with the set support area below giving a sensible place for a stop-loss order. This formation of coming together near highs, after a good earlier rise, is often observed for continuation breakouts.
Worth Context
A key part of any growth stock study is worth to judge if the future growth is already reflected in the price. GMED's Worth score is a neutral 5. The stock's Price/Earnings (P/E) ratio of 21.80 is seen as somewhat high on a pure basis but is less expensive than over 77% of its industry group. Its Price/Forward Earnings ratio tells a like story. This implies that while the stock is not deeply low-priced, its worth seems fair compared to its high-growth, high-earnings peer group in the medical device field. For growth investors, paying a fair price for better quality and growth outlook is often a measured trade.
Summary
Globus Medical offers a case that fits a joined fundamental and technical scanning method. Fundamentally, it shows the signs of a solid growth firm: very good past growth rates, high earnings, and a very strong balance sheet. Technically, it is in a coming together stage within a longer-term upward path, forming near a set resistance level that, if passed, could draw more buyer interest. This meeting of factors, a healthy business appearing in the financial reports and a stock graph that is pausing after a good rise, makes GMED a candidate deserving of more look for investors using this method.
It is key to recall that technical formations are not certainties, and all investments hold risk. The wider market setting, with both the long and short-term paths for the S&P500 now poor, also suggests a careful and choosy method.
Want to locate more stocks that match this profile of solid growth joined with a technical formation? You can run the "Strong Growth Stocks with good Technical Setup Ratings" scan yourself using our stock screener.
Disclaimer: This article is for information only and does not make financial guidance, a suggestion, or an offer or request to buy or sell any securities. The information shown is based on given data and should not be the only base for an investment choice. Investors should do their own separate study and talk with a qualified financial advisor before making any investment choices. Past results are not a guide for future results.